Following China’s pharma scandal, investors are buying into a firm’s claim to be developing a vaccine-tracking blockchain, but not everyone is happy.
Cryptocurrency Financial News
Following China’s pharma scandal, investors are buying into a firm’s claim to be developing a vaccine-tracking blockchain, but not everyone is happy.